NCT07100327 is a NA clinical trial of Band in Morbid Obesity Requiring Bariatric Surgery, sponsored by General Committee of Teaching Hospitals and Institutes, Egypt.

Who is sponsoring NCT07100327?

NCT07100327 is sponsored by General Committee of Teaching Hospitals and Institutes, Egypt.

What drugs are being tested in NCT07100327?

Interventions in NCT07100327: Band, Non-Band.

What condition does NCT07100327 study?

NCT07100327 studies Morbid Obesity Requiring Bariatric Surgery.

Is NCT07100327 still recruiting?

NCT07100327 is currently completed. Last updated 3 August 2025.

Last reviewed 2025-08-03 · How we verify

NCT07100327

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Banded Versus Non-Banded Sleeve in Class IV Obese Patients

Completed NA Last updated 3 August 2025

What this trial tests

NA trial testing Band in Morbid Obesity Requiring Bariatric Surgery in 219 participants. Completed in 15 July 2025.

Timeline

15 June 2022

Primary endpoint
15 June 2025

15 July 2025

Quick facts

Lead sponsor	General Committee of Teaching Hospitals and Institutes, Egypt
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	219
Start date	15 June 2022
Primary completion	15 June 2025
Estimated completion	15 July 2025
Sites	1 location across Egypt

Drugs / interventions tested

Band
Non-Band

Conditions studied

Morbid Obesity Requiring Bariatric Surgery — all drugs for Morbid Obesity Requiring Bariatric Surgery →

Sponsor

General Committee of Teaching Hospitals and Institutes, Egypt

Who can join

Adults 18 to 60, any sex, with Morbid Obesity Requiring Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obesity remains a major global health challenge, with Class IV super obesity (BMI ≥ 50 kg/m²) being the most severe form. This condition is associated with numerous comorbidities including type 2 diabetes, hypertension, obstructive sleep apnea, and hyperlipidemia, which significantly reduce life expectancy and quality of life. Bariatric surgery, particularly sleeve gastrectomy (SG), has been shown to be an effective treatment for morbid obesity. While SG results in significant weight loss and improvement of comorbidities, some patients experience weight regain over time. Banded sleeve gastrectomy (BSG) has been proposed as a modification of SG to enhance long-term outcomes by providing additional restriction via a polypropylene band around the proximal gastric pouch. Although initial evidence for banded procedures suggests improved outcomes, particularly in the context of weight loss and reduced weight regain, specific evidence for Class IV obesity remains limited.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ring-Augmented Versus Non-Ring Augmented Sleeve Gastrectomy in Patients with BMI > 50 kg/m²: 3-Year Follow-up of a Randomized Controlled Trial.
Hany M, El Ansari W, Zidan MH, Abouelnasr AA, et al · · 2026 · PMID 41554945 · DOI 10.1007/s11695-025-08431-1

Verify or expand the search:

Other recruiting trials for Morbid Obesity Requiring Bariatric Surgery

Currently open trials in the same condition.

NCT07073846 — Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. · Phase 4 · recruiting
NCT07087535 — Midterm Follow up Outcomes of (SASJ) in Management of Morbid Obesity · active not recruiting

Other General Committee of Teaching Hospitals and Institutes, Egypt trials

Trials by the same sponsor.

NCT06981923 — Awake Bedside Assessment of The Airway and Evaluation of Tracheal Intubation With CMAC D-Blade or Video Stylet in Bariat · NA · completed
NCT06787924 — Impact of Collagen Supplements on Dermal Collagen in Plastic and Bariatric Surgery Patients · NA · completed
NCT06510452 — Antibiotic Prophylaxis in Metabolic Bariatric Surgery · NA · not yet recruiting
NCT06049758 — D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy · NA · not yet recruiting
NCT05982951 — A Comparative Study Between Ultrasound Guided Shoulder Block and Pericapsular Nerve Group Bock for Shoulder Arthroscopic · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07100327 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by General Committee of Teaching Hospitals and Institutes, Egypt
Last refreshed: 3 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07100327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing